首页|氨甲环酸醇质体的制备及体外评价

氨甲环酸醇质体的制备及体外评价

扫码查看
目的:制备氨甲环酸醇质体(TA@ES),并初步考察其体外透皮性能.方法:采用乙醇注入-挤出法制备TA@ES.通过单因素考察和Box-Behnken设计-响应面法对处方进行筛选及优化;按最优处方制备TA@ES,对其进行质量评价,并进行体外透皮试验.结果:优化后的TA@ES处方脂药比为3.20∶1,胆固醇用量为0.62%,乙醇用量为19.37%.制得的TA@ES为类球形,平均粒径为(194.3±4.1)nm,Zeta电位为(-32.2±2.6)mV,包封率为(17.20±0.89)%.体外透皮试验结果表明,与氨甲环酸水溶液相比,TA@ES不仅提高了药物经皮渗透量(4.98倍),而且还增加了深层皮肤滞留量(1.74倍).结论:制备的TA@ES能够提高氨甲环酸的经皮渗透量和深层皮肤滞留量,有望成为黄褐斑治疗药物的新载体.
Preparation and in vitro Evaluation of Tranexamic Acid Ethosomes
Objective:To prepare tranexamic acid ethosomes(TA@ES),and preliminarily investigate their in vitro permeation.Methods:TA@ES were prepared by an ethanol injection-extrusion method.The formulation was studied by a single-factor method,and then optimized by the Box-Behnken design-response surface method.TA@ES prepared according to the optimal prescription were evaluated for their quality and in vitro permeation.Results:The optimal formulation was as follows:the ratio of phospholipids to tranex-amic acid was 3.20∶1,the dosage of cholesterol was 0.615%,and the dosage of ethanol was 19.366%.The mean particle size of the prepared TA@ES was(194.3±4.1)nm,the Zeta potential was(-32.2±2.6)mV,and the encapsulation efficiency was(17.20%±0.89%).The results of in vitro permeation test showed that the TA@ES not only increased the permeation penetration of the drug(4.98 times),but also increased the deep skin retention(1.74 times),as compared to tranexamic acid aqueous solution.Conclusion:The pre-pared TA@ES can improve the percutaneous penetration and deep skin retention of tranexamic acid,which is expected to be a new vehicle for melasma treatment.

Tranexamic acidEthosomesBox-Behnken design-response surface methodIn vitro per-meation test

余胜男、姜伟化、杜子蝶、李念光、刘飞

展开 >

江苏省中药资源产业化过程协同创新中心 南京中医药大学,南京 210000

南京迈诺威医药科技有限公司,南京 210000

氨甲环酸 醇质体 Box-Behnken设计-响应面法 体外透皮试验

2024

药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
年,卷(期):2024.32(1)
  • 20